One year of treatment with PTH (1-84) and the change in lumbar spine BMD in postmenopausal women with primary osteoporosis after pre-treatment with a bisphosphonate

被引:2
|
作者
Hosking, D. [1 ]
Brandi, M. [2 ]
Diaz-Curiel, M. [3 ]
Felsenberg, D. [4 ,5 ]
Hyldstrup, L. H. [6 ]
机构
[1] City Hosp Nottingham, David Evans Med Res Ctr, Nottingham, England
[2] Univ Florence, Dept Internal Med, Florence, Italy
[3] Univ Autonoma Madrid, Fdn Jimenez Diaz, Med Interna Serv, Madrid, Spain
[4] Free Univ Berlin, Ctr Muscle & Bone Res, Charite, Berlin, Germany
[5] Humboldt Univ, Berlin, Germany
[6] Int Med Sci Strategy & Med Mkt, Nycomed, Roskilde, Denmark
关键词
D O I
10.1016/j.bone.2009.03.371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S428 / S428
页数:1
相关论文
共 50 条
  • [1] Serum calcium values in postmenopausal women with primary osteoporosis after one month of treatment with PTH(1-84)
    Diaz-Curiel, M.
    Hosking, D.
    Rizzoli, R.
    Delmas, P.
    Brandi, M. L.
    Felsenberg, D.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S222 - S222
  • [2] Changes in bone turnover markers and BMD in women with osteoporosis after PTH 1-84 treatment
    Pastore, R.
    Mentuccia, D.
    Borboni, P.
    Frajese, V.
    [J]. BONE, 2009, 44 (02) : S440 - S441
  • [3] Continued increase in hip BMD after 36 months of PTH(1-84) treatment in postmenopausal, women
    Jodar-Gimeno, E.
    Leib, E. S.
    Zanchetta, J. R.
    Mautalen, C. A.
    Greisen, H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S231 - S231
  • [4] Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension study
    Zanchetta, Jose R.
    Bogado, Cesar E.
    Cisari, Carlo
    Aslanidis, Spyros
    Greisen, Hanna
    Fox, John
    Lems, Willem
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (11) : 2627 - 2633
  • [5] Sequential treatment with full-length parathyroid PTH(1-84) of postmenopausal women with primary osteoporosis
    Felsenberg, D.
    Delmas, P.
    Hosking, D.
    Rizzoli, R.
    Brandi, M.
    Diaz-Curiel, M.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S126 - S126
  • [6] TERIPARATIDE AND PTH 1-84 IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH BISPHOSPHONATE-RESISTANT OSTEOPOROSIS: A CASE-CONTROL STUDY
    Loriggiola, L.
    Camozzi, V. I.
    Schiavon, L.
    Salva, M.
    Basso, S. M. M.
    Lumachi, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S193 - S194
  • [7] Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women
    Adami, Silvano
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3259 - 3274
  • [8] Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis
    Black, D. M.
    Bilezikian, J. P.
    Greenspan, S. L.
    Wuester, C.
    Munoz-Torres, M.
    Bone, H. G.
    Rosen, C. J.
    Andersen, H. S.
    Hanley, D. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2013, 24 (04) : 1503 - 1511
  • [9] Serum calcium values after one month's treatment with full-length parathyroid hormone PTH(1-84) of postmenopausal women with primary osteoporosis
    Hosking, D.
    Diaz-Curiel, M.
    Rizzoli, R.
    Delmas, P.
    Brandi, M.
    Felsenberg, D.
    Hyldstrup, L. H.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S130 - S131
  • [10] Acute and chronic effects of PTH(1-84) treatment on heart rate and cardiac repolarization in postmenopausal women with osteoporosis
    Mason, J.
    Moon, T.
    Morris, S.
    Clausen, J. O.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S218 - S218